Global COPD and Asthma Devices Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Inhalers - Drug Powdered Inhalers (Dpis), Metered Dose Inhalers (Mdis) and Soft Mist Inhalers, Nebulizers - Compressor Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers.

By Indication;

Asthma and COPD.

By Distribution Channel;

Retail Pharmacies, Hospitals and Online Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn715064882 Published Date: May, 2024 Updated Date: June, 2024


Global COPD and Asthma Devices Market (USD Million), 2020 - 2030

In the year 2023, the Global COPD and Asthma Devices Market was valued at USD 6,025.72 million. The size of this market is expected to increase to USD 8,490.11 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.

The global Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices market is witnessing significant growth, driven by the rising prevalence of respiratory disorders worldwide. COPD and asthma are chronic respiratory diseases that affect millions of people globally, posing substantial healthcare burdens. These conditions lead to symptoms such as breathlessness, coughing, wheezing, and chest tightness, impacting the quality of life of patients. With increasing awareness about these conditions and advancements in medical technology, the demand for COPD and asthma devices is escalating.

In recent years, there has been a surge in the adoption of advanced respiratory care devices for the management and treatment of COPD and asthma. These devices include inhalers, nebulizers, oxygen therapy equipment, and positive airway pressure devices. Inhalers, particularly metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), have gained prominence due to their convenience, ease of use, and effectiveness in delivering medications directly to the lungs. Nebulizers are also witnessing widespread adoption, especially among patients who have difficulty using inhalers or require higher doses of medication.

The growing elderly population, along with increasing air pollution levels and tobacco smoking, contributes to the escalating prevalence of COPD and asthma globally. This demographic trend, coupled with the rising healthcare expenditure and government initiatives to improve respiratory care, further propels the growth of the COPD and asthma devices market. Additionally, technological advancements such as portable and smart respiratory devices are revolutionizing the management of these conditions, offering personalized and efficient treatment options to patients.

Pandemic has underscored the importance of respiratory health, leading to heightened awareness and focus on preventive measures and effective management of respiratory diseases. As a result, there is a growing emphasis on remote patient monitoring, telehealth services, and home-based care, driving the demand for portable and connected respiratory devices. With the continuous innovation and development of novel therapies and devices, the global COPD and asthma devices market is poised for significant expansion in the coming years, offering new avenues for improving patient outcomes and quality of life.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
  4. Global COPD and Asthma Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements in inhalation
        2. Rising prevalence of COPD
        3. Increasing air pollution levels
        4. Growing geriatric population
        5. Favorable reimbursement policies
      2. Restraints
        1. High cost of devices
        2. Stringent regulatory framework
        3. Limited awareness
        4. Side effects of medications
        5. Challenges in emerging markets
      3. Opportunities
        1. Development of portable devices
        2. Expansion in developing regions
        3. Rising demand for home healthcare
        4. Integration of digital technologies
        5. Personalized treatment approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global COPD and Asthma Devices Market, By Product, 2020 - 2030 (USD Million)
      1. Inhalers
        1. Drug Powdered Inhalers (Dpis)
        2. Metered Dose Inhalers (Mdis)
        3. Soft Mist Inhalers
      2. Nebulizers
        1. Compressor Nebulizers
        2. Ultrasonic Nebulizers
        3. Mesh Nebulizers
    2. Global COPD and Asthma Devices Market, By Indication, 2020 - 2030 (USD Million)
      1. Asthma
      2. COPD
    3. Global COPD and Asthma Devices Market, By Distribution Channel, 2020 - 2030 (USD Million)
      1. Retail Pharmacies
      2. Hospitals
      3. Online Pharmacies
    4. Global COPD and Asthma Devices Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Aerogen, Inc
      2. AstraZeneca PLC
      3. Baxter International Inc
      4. Boehringer Ingelheim International GmbH
      5. 3M COMPANY
      6. GF Health Products, Inc
      7. GlaxoSmithKline Plc
      8. Koninklijke Philips N.V
      9. Novartis AG
      10. PARI medical Holding GMBH
      11. Smiths Group Plc
  7. Analyst Views
  8. Future Outlook of the Market